| Identifiers | |
|---|---|
|
|
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C15H14O3 |
| Molar mass | 242.26986 g/mol |
| 3D model (Jmol) | |
|
|
|
|
(S)-Equol, or (S)-(–)-4',7-isoflavandiol, is the (S)-enantiomer of the naturally occurring isoflavandiol estrogen, equol. It is a non-steroidal, selective agonist of ERβ (Ki = 16 nM), with 13-fold selectivity for ERβ over ERα. Relative to (S)-equol, (R)-equol is less potent and, in contrast, binds to ERα (Ki = 50 nM) with 3.5-fold selectivity over ERβ. Under the code name AUS-131, (S)-equol is under development for the treatment of menopausal symptoms such as hot flashes and benign prostatic hyperplasia.[1] Human intestinal bacteria metabolize the soy isoflavone daidzein into (S)-equol, and it has been determined that (S)-equol is exclusively produced.